New perpective for an old problem: extracellular vesicle based management of respiratory distress syndrome.
作者信息
Engur Defne, Kumral Abdullah
机构信息
Izmir Biomedicine and Genome Center, Izmir, 35330, Turkey.
Izmir International Biomedicine and Genome Institute, Dokuz Eylül University, Izmir, Turkey.
出版信息
Drug Deliv. 2021 Dec;28(1):2310-2312. doi: 10.1080/10717544.2021.1995079.
Abstract
摘要
相似文献
1
New perpective for an old problem: extracellular vesicle based management of respiratory distress syndrome.一个老问题的新视角：基于细胞外囊泡治疗呼吸窘迫综合征
Drug Deliv. 2021 Dec;28(1):2310-2312. doi: 10.1080/10717544.2021.1995079.
2
Current perspectives in the management of respiratory distress syndrome.呼吸窘迫综合征管理的当前观点
Indian Pediatr. 1988 Jul;25(7):654-65.
3
Respiratory distress syndrome and its treatment with surfactant.呼吸窘迫综合征及其表面活性剂治疗
Biochem Soc Trans. 1985 Dec;13(6):1091-2. doi: 10.1042/bst0131091.
4
[Surfactant in the therapy of respiratory distress syndrome].[表面活性剂在呼吸窘迫综合征治疗中的应用]
Cesk Gynekol. 1989 Aug;54(7):516-23.
5
[Surfactant in the therapy of idiopathic respiratory distress syndrome].[表面活性剂在特发性呼吸窘迫综合征治疗中的应用]
Cesk Pediatr. 1993 Jan;48(1):32-6.
6
[Surfactant for the treatment of respiratory distress syndrome].[用于治疗呼吸窘迫综合征的表面活性剂]
Harefuah. 1989 Dec 1;117(11):399-404.
7
[Surfactant replacement--prevention and therapy in respiratory distress syndrome].[表面活性剂替代疗法——呼吸窘迫综合征的预防与治疗]
Harefuah. 1992 Apr 1;122(7):431-3.
8
9
Management of respiratory distress syndrome: an update.呼吸窘迫综合征的管理：最新进展
Pediatr Pulmonol. 2001;Suppl 23:100-2.
10
Exogenous surfactant in neonatal respiratory distress syndrome.外源性表面活性物质在新生儿呼吸窘迫综合征中的应用
R I Med. 1995 Jan;78(1):7-10.
本文引用的文献
1
The biology function and biomedical applications of exosomes.外泌体的生物学功能和生物医学应用。
Science. 2020 Feb 7;367(6478). doi: 10.1126/science.aau6977.
2
Stem-cell therapy for bronchopulmonary dysplasia.干细胞疗法治疗支气管肺发育不良。
Curr Opin Pediatr. 2020 Apr;32(2):210-215. doi: 10.1097/MOP.0000000000000862.
3
Exosomes.外泌体。
Annu Rev Biochem. 2019 Jun 20;88:487-514. doi: 10.1146/annurev-biochem-013118-111902.
4
Biophysical and chemical stability of surfactant/budesonide and the pulmonary distribution following intra-tracheal administration.表面活性剂/布地奈德的物理化学稳定性及其经气管内给药后的肺部分布。
Drug Deliv. 2019 Dec;26(1):604-611. doi: 10.1080/10717544.2019.1618418.
5
Transcriptome of Extracellular Vesicles: State-of-the-Art.细胞外囊泡转录组学：最新进展。
Front Immunol. 2019 Feb 28;10:202. doi: 10.3389/fimmu.2019.00202. eCollection 2019.
6
Nanotherapies for micropreemies: Stem cells and the secretome in bronchopulmonary dysplasia.早产儿的纳米治疗法：干细胞和支气管肺发育不良中的细胞外泌体。
Semin Perinatol. 2018 Nov;42(7):453-458. doi: 10.1053/j.semperi.2018.09.007. Epub 2018 Oct 6.
7
Recent advancements in the use of exosomes as drug delivery systems.最近在将外泌体用作药物传递系统方面的进展。
J Nanobiotechnology. 2018 Oct 16;16(1):81. doi: 10.1186/s12951-018-0403-9.
8
Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation.间充质基质细胞外囊泡通过调节巨噬细胞免疫改善实验性支气管肺发育不良并恢复肺功能。
Am J Respir Crit Care Med. 2018 Jan 1;197(1):104-116. doi: 10.1164/rccm.201705-0925OC.
9
Surfactant for Respiratory Distress Syndrome: New Ideas on a Familiar Drug with Innovative Applications.用于呼吸窘迫综合征的表面活性剂：一种具有创新应用的常见药物的新思路。
Neonatology. 2017;111(4):408-414. doi: 10.1159/000458466. Epub 2017 May 25.
10
Engineering exosomes as refined biological nanoplatforms for drug delivery.将外泌体工程化为用于药物递送的精细生物纳米平台。
Acta Pharmacol Sin. 2017 Jun;38(6):754-763. doi: 10.1038/aps.2017.12. Epub 2017 Apr 10.
Zotero 插件